Article info

Download PDFPDF
Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma

Authors

  1. Correspondence to Professor Dr Alexandar Tzankov, Institute of Pathology, University Hospital Basel, Schoenbeinstrasse 40, Basel CH-4031, Switzerland; atzankov{at}uhbs.ch and Dr Ken H Young, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Holcombe Boulevard, Houston, TX 77030-4009, USA; khyoung{at}mdanderson.org
View Full Text

Citation

Frei E, Visco C, Xu-Monette ZY, et al
Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma

Publication history

  • Received March 13, 2013
  • Revised May 7, 2013
  • Accepted May 23, 2013
  • First published June 17, 2013.
Online issue publication 
October 31, 2013

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.